Navigation Links
Former Speaker of the House Newt Gingrich Featured Wednesday
Date:9/24/2008

Plenary Speaker at AdvaMed 2008 - Book signing to follow his presentation

WASHINGTON, Sept. 24 /PRNewswire-USNewswire/ -- Healthcare policy, regulatory environment, elements of the global marketplace, and the role of financing are focus of the 2008 MedTech Conference.

Wednesday panel presentations will focus on the convergence of the MedTech industry with the wireless & IT sectors, remote patient monitoring technologies, critical issues to consider when entering M&A transactions, China's health care reform, maximizing commercialization, managing suppliers and outsourcing partnerships, the DNA of Selling and other topics of interest. Over the three days the conference has offered industry stakeholders the opportunity to participate in more than 55 panel sessions covering a variety of key industry issues, including: 21st Century Health Policy, Business Development & Finance, Compliance & Best Practices, Emerging Company Issues, Global Business Issues, Legal & Intellectual Property, Medical Technology Production Innovation, Product Quality & Manufacturing Innovation, Quality Management, Regulatory, and Reimbursement.

AdvaMed 2008 also provides sector-specific business development activities ranging from company presentations to partnering meetings as well as numerous networking forums and an extensive exhibition with an innovation alley.

Wednesday keynote plenary speaker is Former Speaker of the House Newt Gingrich. He will participate in a book signing from 9:00 am - 10:00pm immediately following his keynote address. The conference opens at 7:30 am and ends at 1:30 pm.

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.AdvaMed.org.

About AdvaMed 2008:

Designed by industry for industry, AdvaMed 2008 is the premier MedTech conference for business executives, policymakers, media, financiers, and service providers from around the world. In its inaugural year, AdvaMed 2007 attracted more than 400 organizations and 1,100 industry leaders -- including 300+ CEOs, Presidents and C-level executives.

With more than 1,300 senior level attendees expected, AdvaMed 2008 is this year's can't miss event for networking; conducting partnering meetings; educating and influencing policymakers and the media; and participating in education sessions. Whether you need to finance, partner or license technology, AdvaMed 2008 introduces you to key decision-makers. Learn more at http://www.AdvaMed2008.com.


'/>"/>
SOURCE AdvaMed 2008
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cliff Consulting, Inc. Adds Two Influential Former Executives to Its Team - Banker Mary P. Carryer and Healthcare IT Leader Robert Goldstein
2. Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor
3. ADVENTRX Settles Dispute With Former Licensee
4. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
5. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
6. Former CMS Administrator: "Blunt Instrument Policies an Increasingly Bad Fit in Era of Personalized Health Care"
7. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
8. Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO
9. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
10. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
11. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 ... the "Company"), a biopharmaceutical company focused on the development and ... present at the 18 th Annual BIO CEO ... 10:00 a.m. EST in New York, NY ... CEO, will provide an update on the ongoing clinical trial ...
(Date:2/4/2016)... ... 04, 2016 , ... Franz Inc. , an early ... has been recognized As “ Best in Semantic Web Technology - USA & ... America, it’s our priority to showcase prominent professionals who are excelling in their ...
(Date:2/3/2016)... , Feb. 3, 2016  With the growing ... cliff that is underway, therapies such as monoclonal ... a whole host of indications are in high ... in the development and production of these therapeutics. ... quality and high costs, novel approaches and novel ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences ... targets (epitopes) specific to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s ... therapeutics for Alzheimer’s. , Following on from the first misfolded Amyloid beta target ...
Breaking Biology Technology:
(Date:1/13/2016)... 13, 2016 ... of the  "India Biometrics Authentication & ... (2015-2020)"  report to their offering.  ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
(Date:1/7/2016)... LONDON , Jan. 7, 2016 ... demand for biopharmaceutical products such as biologics and ... pressure to reduce healthcare expenditure, growing demand for ... growing aging population. Biosimilars are similar versions of ... with regards to their quality, safety, and efficacy. ...
Breaking Biology News(10 mins):